Long-term outcome of biopsy-proven cholesterol crystal embolism
Sign Up to like & getrecommendations! Published in 2019 at "Clinical and Experimental Nephrology"
DOI: 10.1007/s10157-019-01749-y
Abstract: BackgroundCholesterol crystal embolism (CCE) causes renal damage, and there is an extremely high risk of end-stage renal disease. However, the time course of CCE-related renal deterioration varies and little is known about the subsequent risk… read more here.
Keywords: cce; risk; crystal embolism; renal function ... See more keywords
Successful treatment of cholesterol crystal embolism with anti-proprotein convertase subtilisin/kexin type 9 (PCSK9) antibody: a case report
Sign Up to like & getrecommendations! Published in 2020 at "Renal Failure"
DOI: 10.1080/0886022x.2020.1726383
Abstract: Abstract Background We report a unique case of renal cholesterol crystal embolism (CCE) induced by carotid artery stenting that was successfully treated with evolocumab, a fully human monoclonal antibody against proprotein convertase subtilisin kexin type… read more here.
Keywords: crystal embolism; case; cholesterol; cholesterol crystal ... See more keywords
Efficacy of LDL apheresis for the treatment of cholesterol crystal embolism: A prospective, controlled study
Sign Up to like & getrecommendations! Published in 2021 at "Therapeutic Apheresis and Dialysis"
DOI: 10.1111/1744-9987.13706
Abstract: This study was performed to evaluate the efficacy and safety of LDL apheresis (LDL‐A) for the treatment of cholesterol crystal embolism (CCE) after cardiovascular procedures. We conducted a prospective multicenter study of 34 patients with… read more here.
Keywords: cholesterol crystal; study; apheresis; crystal embolism ... See more keywords